Outcome of MHRA review of neuropsychiatric reactions with montelukast

HM Government

Twitter

Facebook

email

Further measures to be introduced to ensure patients who are prescribed montelukast for the treatment of asthma are informed of the risk of neuropsychiatric reactions

Follow this news feed:

PM call with Prime Minister Pravind Jugnauth of Mauritius: 25 April 2024 Net Zero Council marks year of success and calls for year of action

Leave a Reply Cancel reply